Increased knowledge suggests that disturbed gut microbiota, termed dysbiosis, might
promote the development of irritable bowel syndrome (IBS) symptoms. Accordingly, gut …

Background Treatment is a challenge in Irritable Bowel Syndrome (IBS) and fecal microbiota
transplantation (FMT) has attracted significant interest. Network meta-analysis (NWM) has …

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease that disturbs
the physiology and psychology of patients and increases the burden on families, the …

Background Irritable bowel syndrome (IBS) is associated with intestinal dysbiosis. Therefore,
faecal microbiota transplantation (FMT) has been hypothesised to have a positive effect in …

Objectives Fecal microbiota transplantation (FMT) is a promising intervention for patients
with irritable bowel syndrome (IBS). The present study aimed to identify any differences in …

Background Faecal microbiota transplantation (FMT) has been shown to improve symptoms
in a proportion of patients with irritable bowel syndrome (IBS). Aim We performed a …

Background The study aimed to identify the effects of modeling procedures on bacterial
communities and to investigate whether different modeling procedures lead to consistent …

Introduction Research in recent years has shown the potential benefits of fecal microbiota
transplantation (FMT) for irritable bowel syndrome (IBS). Acute infectious gastroenteritis is a …

Abstract Background and Aims Fecal microbiota transfer (FMT) is a potential treatment for
irritable bowel syndrome (IBS). Several randomized trials have tested FMT effects using …

Background Fecal microbiota transplantation (FMT) has shown excellent efficacy in treating
Clostridioides difficile infection, as well as promise in several other diseases. The …